Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Dis Child ; 102(4): 366-370, 2017 04.
Article in English | MEDLINE | ID: mdl-27765754

ABSTRACT

Children with shunts commonly present with fever, and often the focus of infection will be unrelated to their shunt. However, as shunt infections may present with few or even no specific symptoms, evaluation of a child with a shunt presenting with fever should be careful and comprehensive to ensure shunt infections are not missed. Treatment of an infected shunt involves removal of the shunt followed by a long course of antibiotics; missing or partially treating shunt infections can result in significant morbidity and potentially even mortality. Our experience of managing children with shunts presenting with fever is that many non-specialist clinicians have little experience in this area so initial management may not always be appropriate. Those children who are most at risk of shunt infection are those who within the preceding 8 weeks have had insertion, revision or access of their shunt or chemotherapy device, or have had abdominal surgery in the presence of a ventriculoperitoneal shunt. We have chosen 8 weeks as a pragmatic time point, as in our experience the vast majority of children who have had shunt infections have presented within this period. The caveat is that this should not be used as an absolute cut-off where there is strong suspicion of shunt infection or no clear focus at a later time point.


Subject(s)
Cerebrospinal Fluid Shunts , Fever/therapy , Anti-Bacterial Agents/therapeutic use , Equipment Contamination , Fever/etiology , Humans , Neuroimaging , Patient Discharge Summaries , Surgical Wound Infection/diagnosis , Surgical Wound Infection/etiology , Tomography, X-Ray Computed
2.
BMJ Case Rep ; 20122012 May 08.
Article in English | MEDLINE | ID: mdl-22605835

ABSTRACT

The patient presented with increasing fatigue and dyspnoea. The patient had medical history of rheumatoid arthritis for which she had been taking methotrexate for the past 15 years and etanercept for the past 6 years. Initial diagnosis was cardiac failure but further investigation by echocardiogram revealed a large pericardial effusion. Empirical piperacillin-tazobactam was started due to moderately raised inflammatory markers. Four hundred millilitre of frank pus was aspirated from the pericardial sac and antimicrobial treatment was changed to meropenem. Gram positive cocci were seen in the initial Gram stain, but conventional cultures remained negative. However, 16S ribosomal RNA gene sequencing of the pus sample detected the presence of Parvimonas micra genome. Reaccumulation of the effusion required further drainage where again P micra was detected by 16S ribosomal RNA gene sequencing. Two weeks of meropenem was completed followed by treatment with benzylpenicillin and metronidazole.


Subject(s)
Antirheumatic Agents/adverse effects , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/drug therapy , Immunoglobulin G/adverse effects , Opportunistic Infections/diagnosis , Opportunistic Infections/drug therapy , Opportunistic Infections/microbiology , Pericarditis/diagnosis , Pericarditis/drug therapy , Pericarditis/microbiology , Aged , Anti-Bacterial Agents/therapeutic use , Antirheumatic Agents/therapeutic use , Drug Therapy, Combination , Etanercept , Female , Gram-Positive Bacteria/isolation & purification , Humans , Immunoglobulin G/therapeutic use , Meropenem , Metronidazole/therapeutic use , Penicillin G/therapeutic use , Receptors, Tumor Necrosis Factor/therapeutic use , Risk Factors , Thienamycins/therapeutic use
3.
J Infect ; 54(3): e129-31, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17027086

ABSTRACT

We describe an 80-year-old lady with a meningoencephalitic illness followed by vertebral discitis. Enterococcus avium was cultured from her cerebrospinal fluid. No other pathogen was incriminated in her illness. The meningoencephalitic illness settled after 3 weeks of antimicrobials, but the vertebral discitis required longer therapy.


Subject(s)
Discitis/microbiology , Enterococcus/isolation & purification , Gram-Positive Bacterial Infections/microbiology , Meningoencephalitis/complications , Meningoencephalitis/microbiology , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Cerebrospinal Fluid/microbiology , Discitis/drug therapy , Female , Humans , Meningoencephalitis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...